Atrandi Biosciences, a Vilnius, Lithuania and Denver, CO-based provider of microfluidic solutions for the life sciences, raised $4.8M in funding.
The round, which brought total funding to over $8M, was led by Vsquared Ventures, Practica Capital and Metaplanet.
The company intends to use the funds to support a worldwide commercial organisation, enabling a direct U.S. presence.
Founded in 2016 and led by CEO Juozas Nainys, Atrandi Biosciences is an emerging developer and provider of microfluidic solutions for the life sciences. Its technology platform enables insights into the biology of single cells, with applications in research and bio-molecular discovery. Its systems are installed in over 50 academic and commercial laboratories globally with a rapid growth trajectory.
FinSMEs
28/03/2023